The iLCT Pipeline Research Acceleration Programme is a targeted funding call launched by Cure Parkinson’s to accelerate high-priority therapeutic candidates toward clinical trials for Parkinson’s disease. This programme forms part of the International Linked Clinical Trials (iLCT) initiative, a
The Draper Richards Kaplan Foundation (DRK Foundation) provides early-stage capital and intensive capacity-building support to bold social enterprises tackling the world’s most pressing social and environmental challenges. DRK funds mission-driven organisations that serve vulnerable, marginalized